Company / Net Debt per Share
X4 Pharmaceuticals, Inc Net Debt per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$24.93
FY2025
5-year range
-$24.93 / $1.51
FY2021-FY2025
Trend
-21725.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share changed -21725% YoY in FY2025, a notable deviation from the 5-year average annual change of -4347%.
Based on SEC 10-K filings.
-24.93 in FY2025.
Improved from $-1.75 to $-24.93 over the past 3 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net debt per share decreased 21725.4% year-over-year.
- Peak net debt per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$24.93 | -21725.4% |
| FY2024 | $0.12 | +106.6% |
| FY2022 | -$1.75 | +38.2% |
| FY2021 | -$2.83 | -287.6% |
| FY2020 | $1.51 | +132.2% |
| FY2018 | -$4.69 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026